**Question:** All of the following are true about HMG CoA reductase inhibitor except

A. It is a competitive inhibitor of HMG-CoA reductase.
B. It is a statin drug.
C. It causes an increase in LDL cholesterol levels.
D. It is a non-steroidal anti-inflammatory drug (NSAID).

**Correct Answer:** D. It is a non-steroidal anti-inflammatory drug (NSAID).

**Core Concept:** HMG CoA reductase inhibitors, also known as statins, are a class of medications primarily used to lower cholesterol levels. They exert their effect by inhibiting the enzyme HMG-CoA reductase, which is involved in the cholesterol synthesis pathway.

**Why the Correct Answer is Right:** HMG CoA reductase inhibitors are indeed competitive inhibitors of HMG-CoA reductase. They bind to the active site of the enzyme, competing with the substrate (HMG-CoA) for binding. This results in a decrease in the availability of HMG-CoA for the enzyme, which in turn leads to a reduction in cholesterol synthesis.

**Why Each Wrong Option is Incorrect:**

A. HMG CoA reductase inhibitors are indeed statins, a subgroup of HMG CoA reductase inhibitors. They are used to lower cholesterol levels by inhibiting the enzyme HMG-CoA reductase, as explained above.

B. Statins are a specific type of HMG CoA reductase inhibitor, not an NSAID (Non-steroidal Anti-inflammatory Drugs). NSAIDs are a class of drugs that work by inhibiting the enzyme cyclooxygenase (COX), which is involved in the synthesis of prostaglandins.

C. HMG CoA reductase inhibitors can indeed lead to an increase in LDL cholesterol levels, known as the "statin paradox". However, they also increase HDL cholesterol levels and reduce triglycerides, which counteracts the initial LDL increase.

D. NSAIDs, being a type of drug that inhibits the enzyme COX, work primarily to reduce inflammation and pain by blocking the synthesis of prostaglandins. These drugs have no effect on cholesterol levels and are not used for cholesterol management.

**Clinical Pearl:** Understanding the mechanism of action of statins is crucial for making an informed decision when choosing appropriate medications for cholesterol management. Statins, specifically HMG CoA reductase inhibitors, are indicated for patients with hyperlipidemia, coronary artery disease, or those at high risk for cardiovascular events. They are a primary treatment option for these patients to reduce cholesterol synthesis and lower LDL cholesterol levels, while increasing HDL cholesterol and reducing triglycerides. NSAIDs, on the other hand, target inflammation and pain by inhibiting the synthesis of prostaglandins and are not used for cholesterol management.